An Overview of the Consequences of Distal Coronary Microembolization on Left Ventricular Function, Perfusion and Viability
Maythem Saeed
DOI: 10.4236/ijcm.2011.21009   PDF    HTML     5,625 Downloads   9,023 Views   Citations


Annually, an estimated 1,285,000 in-patient angioplasty procedures, 1,471,000 inpatient diagnostic cardiac catheteri-zations and 68,000 inpatient defibrillator implantations are performed. The direct and indirect cost of cardiovascular diseases for 2007 is approximately $431.8 billion. The occurrence of plaque rupture with subsequent microemboli of atherosclerotic and thrombolytic debris into small coronary vessels has been confirmed. Microinfarction results from microemboli that are shed following coronary interventions. The aims of this review are to: 1) detect heterogeneous microinfarction using viability imaging, 2) characterize the consequences of distal coronary microembolization on left ventricle function and perfusion and 3) illustrate the progress of non-invasive imaging modalities in assessing distal coronary microembolization.

Share and Cite:

M. Saeed, "An Overview of the Consequences of Distal Coronary Microembolization on Left Ventricular Function, Perfusion and Viability," International Journal of Clinical Medicine, Vol. 2 No. 1, 2011, pp. 40-50. doi: 10.4236/ijcm.2011.21009.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] C. A. Beltrami, N. Finato, M. Rocco, G. A. Feruglio, C. Puricelli, E. Cigola, F. Quaini, E. H. Sonnenblick, G. Olivetti and P. Anversa, “Structural Basis of End-Stage Failure in Ischemic Cardiomyopathy in Humans,” Circulation, Vol. 89, No. 1, 1994, pp. 151-163.
[2] C. Klein, S. G. Nekolla, F. M. Bengel, M. Momose, A. Sammer, F. Haas, B. Schnackenburg, W. Delius, H. Mudra, et al., “Assessment of Myocardial Viability with Contrast-Enhanced Magnetic Resonance Imaging: Comparison with Positron Emission Tomography,” Circulation Vol. 105, No. 2, 2002, pp. 162-167. doi:10.1161/hc0202.102123
[3] R. E. Anderson, “How Many Deaths are Due to Medical Errors?” Jama, Vol. 284, No. 17, 2000, pp. 2188-2189.
[4] D. Antoniucci, R. Valenti, A. Migliorini, G. Moschi, G. Parodi, E. V. Dovellini, L. Bolognese and G. M. Santoro, “Comparison of Impact of Emergency Percutaneous Revascularization on Outcome of Patients > or =75 to Those < 75 Years of Age with Acute Myocardial Infarction Complicated by Cardiogenic Shock,” American Journal of Cardiology, Vol. 91, 2003, pp. 1458-1461. doi:10.1016/S0002-9149(03)00397-7
[5] L. Bolognese, N. Carrabba, G. Parodi, G. M. Santoro, P. Buonamici, G. Cerisano and D. Antoniucci, “Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction,” Circulation Vol. 109, No. 9, 2004, pp. 1121-1126. doi:10.1161/01.CIR.0000118496.44135.A7
[6] L. Bolognese, N. Carrabba, G. M. Santoro, R. Valenti, P. Buonamici and D. Antoniucci, “Angiographic Findings, Time Course of Regional and Global Left Ventricular Function, and Clinical Outcome in Diabetic Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Transluminal Coronary Angioplasty,” Ame- rican Journal of Cardiology, Vol. 91, No. 5, 2003, pp. 544-549. doi:10.1016/S0002-9149(02)03302-7
[7] V. Caraballo, “Fatal Myocardial Infarction Resulting from Coronary Artery Septic Embolism after Abortion: Unusual Cause and Complication of Endocarditis,” Annals of Emergency Medicine, Vol. 29, No. 1, 1997, pp. 175-177. doi:10.1016/S0196-0644(97)70325-1
[8] R. G. Charles, E. J. Epstein, S. Holt and N. Coulshed, “Coronary Embolism in Valvular Heart Disease,” Quarterly Journal of Medicine, Vol. 51, No. 202, 1982, pp. 147-161.
[9] E. Donal, D. Coisne, Y. Valy, J. Allal, L. Christaens and R. Barraine, “Myocardial Infarction Caused by Septic Embolism during Mitral Endocarditis,” Archives des maladies du coeur et des vaisseaux, Vol. 92, No. 2, 1999, pp. 253-257.
[10] N. Noto, T. Osaka, O. Yamanaka, S. Kobayashi, H. Ozaki and T. Kanoh, “A Case of Acute Myocardial Infarction Due to Coronary Embolism from Left Atrial Thrombus with Atrial Fibrillation,” Kokyu To Junkan, Vol. 38, No. 5, 1990, pp. 483-487, in Japanese.
[11] E. G. Quinn and D. J. Fergusson, “Coronary Embolism Following Aortic and Mitral Valve Replacement: Successful Management with Abciximab and Urokinase,” Catheterization and cardiovascular diagnosis, Vol. 43, No. 4, 1998, pp. 457-459. doi:10.1002/(SICI)1097-0304(199804)43:4<457::AID-CCD24>3.0.CO;2-F
[12] T. Takenaka, M. Horimoto, K. Igarashi, H. Yoshie, I. Tsujino and M. Morihira, “Multiple Coronary Throm- boemboli Complicating Valvular Heart Disease and Atrial Fibrillation,” American Heart Journal, Vol. 131, No. 1, 1996, pp. 194-196. doi:10.1016/S0002-8703(96)90070-8
[13] C. Yutani, M. Imakita, H. Ueda-Ishibashi, M. Katsuragi and H. Fujita, “Coronary Artery Embolism with Special Reference to Invasive Procedures as the Source,” Modern Pathology, Vol. 5, No. 3, 1992, pp. 244-249.
[14] R. Erbel, “Spontaneous and Interventional Coronary Microembolisation,” Heart, Vol. 89, No. 8, 2003, pp. 986-989. doi:10.1136/heart.89.9.986
[15] B. F. Mandell, “Cardiovascular Involvement in Systemic Lupus Erythematosus,” Semin Arthritis Rheum, Vol. 17, No. 2, 1987, pp. 126-141.
[16] M. A. Westwood, F. Shah, L. J. Anderson, J. W. Strange, M. A. Tanner, A. M. Maceira, J. Howard, J. B. Porter, J. M. Walker, et al., “Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy,” Journal of Magnetic Resonance Imaging, Vol. 26, 2007, pp. 564-568. doi:10.1002/jmri.21018
[17] J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey, Jr., W. E. Chavey, 2nd, F. M. Fesmire, J. S. Hochman, et al., “ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/Ame- rican Heart Association Task Force on Practice Guide- lines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/ Non-ST-Elevation Myocardial Infa
[18] R. Hardoff, A. Shefer, S. Gips, A. Merdler, M. Y. Flugelman, D. A. Halon and B. S. Lewis, “Predicting Late Restenosis after Coronary Angioplasty by Very Early (12 to 24 h) Thallium-201 Scintigraphy: Implications with Regard to Mechanisms of Late Coronary Restenosis,” Journal of the American College of Cardiology, Vol. 15, No. 7, 1990, pp. 1486-1492. doi:10.1016/0735-1097(90)92815-J
[19] A. Jain, J. J. Mahmarian, S. Borges-Neto, D. L. Johnston, W. R. Cashion, J. M. Lewis, A. E. Raizner and M. S. Verani, “Clinical Significance of Perfusion Defects by Thallium-201 Single Photon Emission Tomography Following Oral Dipyridamole Early After Coronary Angioplasty,” Journal of the American College of Cardiology, Vol. 11, No. 5, 1988, pp. 970-976.
[20] W. Wijns, P. W. Serruys, J. H. Reiber, P. J. de Feyter, M. van den Brand, M. L. Simoons and P. G. Hugenholtz, “Early Detection of Restenosis after Successful Percu- taneous Transluminal Coronary Angioplasty by Exercise- Redistribution Thallium Scintigraphy,” American Journal of Cardiology, Vol. 55, No. 4, 1985, pp. 357-361. doi:10.1016/0002-9149(85)90375-3
[21] W. W. Wijns and P. W. Serruys, “Coronary Angioplasty in Myocardial Infarction,” American Journal of Cardiology, Vol. 56, 1985, p. 1004. doi:10.1016/0002-9149(85)90430-8
[22] R. Bachmann, U. Sechtem, E. Voth, J. Schroder, H. W. Hopp and H. Schicha, “Dipyridamole Scintigraphy and Intravascular Ultrasound after Successful Coronary Intervention,” Journal of Nuclear Medicine, Vol. 38, No. 4, 1997, pp. 553-558.
[23] D. R. Holmes, Jr., “Very Early Prediction of Restenosis after Successful Coronary Angioplasty: How Early is Early and can We Identify it?” Journal of American College Cardiology, Vol. 15, No. 2, 1990, pp. 265-266.
[24] J. Rodes-Cabau, J. Candell-Riera, E. Domingo, J. Castell- Conesa, I. Anivarro, J. Angel, S. Aguade-Bruix, F. Padilla, A. Soto and J. Soler-Soler, “Frequency and Clinical Significance of Myocardial Ischemia Detected Early after Coronary Stent Implantation,” Journal Nuclear Medicine, Vol. 42, No. 12, 2001, pp. 1768-1772.
[25] R. Jaffe, S. B. Haim, B. Karkabi, A. Front, S. Gips, G. Weisz, N. Khader, A. Merdler, M. Y. Flugelman, et al., “Myocardial Perfusion Abnormalities Early (12-24 h) after Coronary Stenting or Balloon Angioplasty: Implications Regarding Pathophysiology and Late Clinical Outcome,” Cardiology, Vol. 98, No. 1-2, 2002, pp. 60-66. doi:10.1159/000064680
[26] H. Nagaoka, T. Iizuka, S. Kubota, M. Inoue, E. Yamaguchi, T. Suzuki and R. Nagai, “Redistribution in Thallium-201 Myocardial Imaging Soon after Successful Coronary Stenting—Tomographic Evaluation during Coronary Hyperemia Induced by Adenosine,” Japanese Circulation Journal, Vol. 62, No. 3, 1998, pp. 160-166. doi:10.1253/jcj.62.160
[27] A. Skyschally, R. Schulz, R. Erbel and G. Heusch, “Reduced Coronary and Inotropic Reserves with Coronary Microembolization,” American Journal of Physiology - Heart and Circulatory Physiology, Vol. 282, No. 2, 2002, pp. H611-614.
[28] I. Porto, J. B. Selvanayagam, W. J. Van Gaal, F. Prati, A. Cheng, K. Channon, S. Neubauer and A. P. Banning, “Plaque Volume and Occurrence and Location of Periprocedural Myocardial Necrosis after Percutaneous Coronary Intervention: Insights from Delayed-Enhance- ment Magnetic Resonance Imaging, Thrombolysis in Myocardial Infarction Myocardial Perfusion Grade Analysis, and Intravascular Ultrasound,” Circulation, Vol. 114, No. 7, 2006, pp. 662-669. doi:10.1161/CIRCULATIONAHA.105.593210
[29] E. Falk, “Unstable Angina with Fatal Outcome: Dynamic Coronary Thrombosis Leading to Infarction and/or Sudden Death. Autopsy Evidence of Recurrent Mural Thrombosis with Peripheral Embolization Culminating in Total Vascular Occlusion,” Circulation, Vol. 71, No. 4, 1985, pp. 699-708.
[30] J. B. Selvanayagam, A. S. Cheng, M. Jerosch-Herold, K. Rahimi, I. Porto, W. van Gaal, K. M. Channon, S. Neubauer and A. P. Banning, “Effect of Distal Embo- lization on Myocardial Perfusion Reserve after Percu- taneous Coronary Intervention: A Quantitative Magnetic Resonance Perfusion Study,” Circulation, Vol. 116, No. 13, 2007, pp. 1458-1464. doi:10.1161/CIRCULATIONAHA.106.671909
[31] M. J. Davies and A. C. Thomas, “Plaque Fissuring—The Cause of Acute Myocardial Infarction, Sudden Ischaemic Death, and Crescendo Angina,” British Heart Journal, Vol. 53, No. 4, 1985, pp. 363-373. doi:10.1136/hrt.53.4.363
[32] M. J. Davies, A. C. Thomas, P. A. Knapman and J. R. Hangartner, “Intramyocardial Platelet Aggregation in Patients with Unstable Angina Suffering Sudden Ischemic Cardiac Death,” Circulation Vol. 73, 1986, pp. 418-427.
[33] A. Skyschally, K. Leineweber, P. Gres, M. Haude, R. Erbel and G. Heusch, “Coronary Microembolization,” Basic Research in Cardiology Vol. 101, No. 5, 2006, pp. 373-382. doi:10.1007/s00395-006-0616-1
[34] R. Erbel and G. Heusch, “Coronary Microembolization,” Journal of the American College of Cardiology, Vol. 36, No. 1, 2000, pp. 22-24. doi:10.1016/S0735-1097(00)00708-7
[35] M. J. Davies, J. M. Bland, J. R. Hangartner, A. Angelini and A. C. Thomas, “Factors Influencing the Presence or Absence of Acute Coronary Artery Thrombi in Sudden Ischaemic Death,” European Heart Journal, Vol. 10, No. 3, 1989, pp. 203-208.
[36] M. J. Davies and A. Thomas, “Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death,” New England Journal of Medicine, Vol. 310, 1984, pp. 1137-1140. doi:10.1056/NEJM198405033101801
[37] A. Farb, A. L. Tang, A. P. Burke, L. Sessums, Y. Liang and R. Virmani, “Sudden Coronary Death. Frequency of Active Coronary Lesions, Inactive Coronary Lesions, and Myocardial Infarction,” Circulation, Vol. 92, 1995, pp. 1701-1709.
[38] I. H. Leach, J. W. Blundell, J. M. Rowley and D. R. Turner, “Acute Ischaemic Lesions in Death Due to Ischaemic Heart Disease. An Autopsy Study of 333 Cases of Out-of-Hospital Death,” European Heart Journal, Vol. 16, No. 9,1995, pp. 1181-1185.
[39] M. Michalodimitrakis, A. Mavroforou and A. D. Giannoukas, “Lessons Learnt from the Autopsies of 445 Cases of Sudden Cardiac Death in Adults,” Coronary Artery Disease, Vol. 16, No. 6, 2005, pp. 385-389.
[40] D. D. Reichenbach, N. S. Moss and E. Meyer, “Pathology of the Heart in Sudden Cardiac Death,” American Journal of Cardiology, Vol. 39, No. 6, 1977, pp. 865-872.
[41] A. Schubert, “Remarks to Statement from the Rate of Cause of Death Due to Ischaemic Heart Diseases,” Gesundheitswesen, Vol. 63, No. 12, 2001, pp. 769-774.
[42] P. T. Sexton, K. Jamrozik and J. Walsh, “Sudden Unexpected Cardiac Death among Tasmanian Men,” Medical Journal of Australia, Vol. 159, No. 7, 1993, pp. 467-470.
[43] A. Okamura, H. Ito, K. Iwakura, S. Kawano, K. Inoue, Y. Maekawa, T. Ogihara and K. Fujii, “Detection of Embolic Particles with the Doppler Guide Wire during Coronary Intervention in Patients with Acute Myocardial Infarction: Efficacy of Distal Protection Device,” Journal of the American College of Cardiology, Vol. 45, No. 2, 2005, pp. 212-215. doi:10.1016/j.jacc.2004.09.062
[44] R. S. Saber, W. D. Edwards, K. R. Bailey, T. W. McGovern, R. S. Schwartz and D. R. Holmes, Jr., “Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases,” Journal of the American College of Cardiology Vol. 22, 1993, pp. 1283-1288.
[45] D. Bose, C. von Birgelen, X. Y. Zhou, A. Schmermund, S. Philipp, S. Sack, T. Konorza, S. Mohlenkamp, K. Leineweber, et al., “Impact of Atherosclerotic Plaque Composition on Coronary Microembolization during Percutaneous Coronary Interventions,” Basic Research Cardiology, Vol. 103, No. 6, 2008, pp. 587-597. doi:10.1007/s00395-008-0745-9
[46] A. Angelini, P. Rubartelli, F. Mistrorigo, M. Della Barbera, F. Abbadessa, M. Vischi, G. Thiene and S. Chierchia, “Distal Protection with a Filter Device during Coronary Stenting in Patients with Stable and Unstable Angina,” Circulation, Vol. 110, No. 6, 2004, pp. 515-521.
[47] G. Heusch, R. Schulz, M. Haude and R. Erbel, “Coronary Microembolization,” Journal of Molecular and Cellular Cardiology, Vol. 37, 2004, pp. 23-31. doi:10.1016/j.yjmcc.2004.04.011
[48] R. Erbel and G. Heusch, “Spontaneous and Iatrogenic Microembolization. A New Concept for the Pathogenesis of Coronary Artery Disease,” Herz, Vol. 24, No. 7, 1999, pp. 493-495. doi:10.1007/BF03044219
[49] R. Erbel and G. Heusch, “Coronary microembolization— Its Role in Acute Coronary Syndromes and Interven- tions,” Herz, Vol. 24, No. 7, 1999, pp. 558-575. doi:10.1007/BF03044228
[50] E. J. Topol and J. S. Yadav, “Recognition of the Impor- tance of Embolization in Atherosclerotic Vascular Disea- se,” Circulation, Vol. 101, No. 5, 2000, pp. 570-580.
[51] A. Skyschally, M. Haude, H. Dorge, M. Thielmann, A. Duschin, A. van de Sand, I. Konietzka, A. Buchert, S. Aker, et al., “Glucocorticoid Treatment Prevents Pro- gressive Myocardial Dysfunction Resulting from Experi- mental Coronary Microembolization,” Circulation, Vol. 109, No. 19, 2004, pp. 2337-2342. doi:10.1161/01.CIR.0000127961.66744.F4
[52] M. A. Pfeffer, J. M. Pfeffer, M. C. Fishbein, P. J. Fletcher, J. Spadaro, R. A. Kloner and E. Braunwald, “Myocardial Infarct Size and Ventricular Function in Rats,” Circu- lation Research, Vol. 44, No. 4, 1979, pp. 503-512.
[53] H. Dorge, T. Neumann, M. Behrends, A. Skyschally, R. Schulz, C. Kasper, R. Erbel and G. Heusch, “Perfusion- Contraction Mismatch with Coronary Microvascular Obstruction: Role of Inflammation,” American Journal of Physiology - Heart and Circulatory Physiology, Vol. 279, No. 6, 2000, pp. 2587-2592.
[54] R. S. Schwartz, A. Burke, A. Farb, D. Kaye, J. R. Lesser, T. D. Henry and R. Virmani, “Microemboli and Micro- vascular Obstruction in Acute Coronary Thrombosis and Sudden Coronary Death: Relation to Epicardial Plaque Histopathology,” Journal of the American College of Cardiology, Vol. 54, No. 23, 2009, pp. 2167-2173.
[55] M. Carlsson, M. Wilson, A. J. Martin and M. Saeed, “Myocardial Microinfarction after Coronary Microem- bolization in Swine: MR Imaging Characterization,” Radiology, Vol. 250, No. 3, 2009, pp. 703-713.
[56] M. Carlsson, A. J. Martin, P. C. Ursell, D. Saloner and M. Saeed, “Magnetic Resonance Imaging Quantification Of Left Ventricular Dysfunction Following Coronary Micro- embolization,” Magnetic Resonance in Medicine, Vol. 61, No. 3, 2009, pp. 595-602.
[57] Y. Gu, Y. Bai, J. Wu, L. Hu and B. Gao, “Establishment and Characterization of an Experimental Model of Coronary Thrombotic Microembolism in Rats,” American Journal of Pathology, Vol. 177, No. 3, 2010, pp. 1122- 1130. doi:10.2353/ajpath.2010.090889
[58] D. L. Dicks, M. Carlsson, E. Heiberg, A. Martin, D. Saloner, H. Arheden and M. Saeed, “Persistent Decline in Longitudinal and Radial Strain after Coronary Microembolization Detected on Velocity Encoded Phase Contrast Magnetic Resonance Imaging,” Journal of Magnetic Resonance Imaging, Vol. 30, No. 1, 2009, pp. 69-76. doi:10.1002/jmri.21773
[59] M. Carlsson, D. Saloner, A. J. Martin, P. C. Ursell and M. Saeed, “Heterogeneous Microinfarcts Caused by Coronary Microemboli: Evaluation with Multidetector CT and MR Imaging in a Swine Model,” Radiology, Vol. 254, No. 3, 2010, pp. 718-728.
[60] M. Carlsson, N. F. Osman, P. C. Ursell, A. J. Martin and M. Saeed, “Quantitative MR Measurements of Regional and Global Left Ventricular Function and Strain after Intramyocardial Transfer of VM202 into Infarcted Swine Myocardium,” American Journal of Physiology - Heart and Circulatory Physiology, Vol. 295, No. 2, 2008, pp. 522-532. doi:10.1152/ajpheart.00280.2008
[61] D. Dicks, D. Saloner, A. Martin, P. Ursell, M. Carlsson and M. Saeed, “Cardiovascular Magnetic Resonance Imaging for Percutaneous Transendocardial Delivery and Three Dimensional Left Ventricular Strain Assessment of VEGF Gene Therapy in Occlusive Infarction,” International Journal of Cardiology (2009 (in press) PMID: 19346019 ).
[62] A. Jacquier, C. B. Higgins, A. J. Martin, L. Do, D. Saloner and M. Saeed, “Injection of Adeno-Associated Viral Vector Encoding Vascular Endothelial Growth Factor Gene in Infarcted Swine Myocardium: MR Measurements of Left Ventricular Function and Strain,” Radiology, Vol. 245, No. 1, 2007, pp. 196-205.
[63] M. Saeed, A. Martin, A. Jacquier, M. Bucknor, D. Saloner, L. Do, P. Ursell, H. Su, Y. W. Kan and C. B. Higgins, “Permanent Coronary Artery Occlusion: Cardio- vascular MR Imaging is Platform for Percutaneous Transendocardial Delivery and Assessment of Gene Therapy in Canine Model,” Radiology, Vol. 249, No. 2, 2008, pp. 560-571. doi:10.1148/radiol.2491072068
[64] M. Saeed, A. Martin, P. Ursell, L. Do, M. Bucknor, C. B. Higgins and D. Saloner, “MR Assessment of Myocardial Perfusion, Viability, and Function after Intramyocardial Transfer of VM202, a New Plasmid Human Hepatocyte Growth Factor in Ischemic Swine Myocardium,” Radi- ology, Vol. 249, No. 1, 2008, pp. 107-118.
[65] M. Saeed, D. Saloner, A. Martin, L. Do, O. Weber, P. C. Ursell, A. Jacquier, R. Lee and C. B. Higgins, “Adeno- Associated Viral Vector-Encoding Vascular Endothelial Growth Factor Gene: Effect on Cardiovascular MR Perfu- sion and Infarct Resorption Measurements in Swine,” Radiology, Vol. 243, No. 2, 2007, pp. 451-460.
[66] M. Saeed, O. Weber, R. Lee, L. Do, A. Martin, D. Saloner, P. Ursell, P. Robert, C. Corot and C. B. Higgins, “Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging with Intravascular Magnetic Resonance Contrast Media,” Journal of the American College of Cardiology, Vol. 48, No. 10, 2006, pp. 1961-1968. doi:10.1016/j.jacc.2006.03.071
[67] M. Saeed, A. J. Martin, R. J. Lee, O. Weber, D. Revel, D. Saloner and C. B. Higgins, “MR Guidance of Targeted Injections into Border and Core of Scarred Myocardium in Pigs,” Radiology, Vol. 240, No. 2, 2006, pp. 419-426.
[68] M. J. Ricciardi, E. Wu, C. J. Davidson, K. M. Choi, F. J. Klocke, R. O. Bonow, R. M. Judd and R. J. Kim, “Visualization of Discrete Microinfarction after Percutaneous Coronary Intervention Associated with Mild Creatine Kinase-MB Elevation,” Circulation, Vol. 103, No. 23, 2001, pp. 2780-2783. doi:10.1161/hc2301.092121
[69] J. B. Selvanayagam, I. Porto, K. Channon, S. E. Petersen, J. M. Francis, S. Neubauer and A. P. Banning, “Troponin Elevation after Percutaneous Coronary Intervention Directly Represents The Extent of Irreversible Myocardial Injury: Insights from Cardiovascular Magnetic Resonance Imaging,” Circulation, Vol. 111, No. 8, 2005, pp. 1027-1032.
[70] K. Nassenstein, F. Breuckmann, C. Bucher, G. Kaiser, T. Konorza, L. Schafer, I. Konietzka, A. de Greiff, G. Heusch, et al., “How Much Myocardial Damage is Necessary to Enable Detection of Focal Late Gadolinium Enhancement at Cardiac MR Imaging?” Radiology, Vol. 249, No. 3, 2008, pp. 829-835. doi:10.1148/radiol.2493080457
[71] F. Breuckmann, K. Nassenstein, C. Bucher, I. Konietzka, G. Kaiser, T. Konorza, C. Naber, A. Skyschally, P. Gres, et al., “Systematic Analysis of Functional and Structural Changes After Coronary Microembolization: A Cardiac Magnetic Resonance Imaging Study,” Journal of the American College of Cardiology, Vol. 2, 2009, pp. 121-130.
[72] M. Saeed, S. Hetts, J. English, L. Do and M. Wilson, “Quantitative and Qualitative Characterization of the Acute Changes in Myocardial Structure and Function after Distal Coronary Microembolization Using MDCT,” Academic Radiology, 2011, in press. doi:10.1016/j.acra.2010.11.016
[73] J. B. Selvanayagam, A. Kardos, D. Nicolson, J. Francis, S. E. Petersen, M. Robson, A. Banning and S. Neubauer, “Anteroseptal or Apical Myocardial Infarction: A Controversy Addressed Using Delayed Enhancement Cardiovascular Magnetic Resonance Imaging,” Journal of Cardiovascular Magnetic Resonance, Vol. 6, 2004, pp. 653-661. doi:10.1081/JCMR-120038647
[74] J. B. Selvanayagam, S. E. Petersen, J. M. Francis, M. D. Robson, A. Kardos, S. Neubauer and D. P. Taggart, “Effects of Off-Pump Versus On-Pump Coronary Surgery on Reversible and Irreversible Myocardial Injury: A Randomized Trial Using Cardiovascular Magnetic Resonance Imaging and Biochemical Markers,” Circulation, Vol. 109, No. 3, 2004, pp. 345-350. doi:10.1161/01.CIR.0000109489.71945.BD
[75] J. W. Choi, C. M. Gibson, S. A. Murphy, C. J. Davidson, R. J. Kim and M. J. Ricciardi, “Myonecrosis Following Stent Placement: Association between Impaired TIMI Myocardial Perfusion Grade and MRI Visualization of Microinfarction,” Catheterization and Cardiovascular Interventions, Vol. 61, No. 4, pp. 472-476 2004.
[76] A. C. Lardo, M. A. Cordeiro, C. Silva, L. C. Amado, R. T. George, A. P. Saliaris, K. H. Schuleri, V. R. Fernandes, M. Zviman, et al., “Contrast-Enhanced Multidetector Computed Tomography Viability Imaging after Myocardial Infarction: Characterization of Myocyte Death, Microvascular Obstruction, and Chronic Scar,” Circulation, Vol. 113, No. 3, 2006, pp. 394-404. doi:10.1161/CIRCULATIONAHA.105.521450
[77] A. Jacquier, L. Boussel, N. Amabile, J. M. Bartoli, P. Douek, G. Moulin, F. Paganelli, M. Saeed, D. Revel and P. Croisille, “Multidetector Computed Tomography in Reperfused Acute Myocardial Infarction. Assessment of Infarct Size and No-Reflow in Comparison With Cardiac Magnetic Resonance Imaging,” Investigative Radiology, Vol. 43, No. 11, 2008, pp. 773-781.
[78] B. L. Gerber, E. Coche, A. Pasquet, E. Ketelslegers, D. Vancraeynest, C. Grandin, B. E. Van Beers and J. L. Vanoverschelde, “Coronary Artery Stenosis: Direct Comparison of Four-Section Multi-Detector Row CT and 3D Navigator MR Imaging for Detection—Initial Results,” Radiology, Vol. 234, No. 1, 2005, pp. 98-108.
[79] B. L. Gerber, B. Belge, G. J. Legros, P. Lim, A. Poncelet, A. Pasquet, G. Gisellu, E. Coche and J. L. Vano- verschelde, “Characterization of Acute and Chronic Myocardial Infarcts by Multidetector Computed Tomo- graphy: Comparison with Contrast-Enhanced Magnetic Resonance,” Circulation, Vol. 113, No. 6, 2006, pp. 823- 833. doi:10.1161/CIRCULATIONAHA.104.529511
[80] A. D. Furtado, M. Carlsson, M. Wintermark, K. Ordovas and M. Saeed, “Identification of Residual Ischemia, Infarction, and Microvascular Impairment in Revas- cularized Myocardial Infarction Using 64-Slice MDCT,” Contrast Media Molecular Imaging, Vol. 3, No. 5, 2008, pp. 198-206. doi:10.1002/cmmi.253
[81] R. B. Jennings, C. Steenbergen, Jr. and K. A. Reimer, “Myocardial Ischemia and Reperfusion,” Monographs in Pathology, Vol. 37, 1995, pp. 47-80.
[82] R. T. George, M. Jerosch-Herold, C. Silva, K. Kitagawa, D. A. Bluemke, J. A. Lima and A. C. Lardo, “Quan- tification of Myocardial Perfusion Using Dynamic 64- Detector Computed Tomography,” Investgative Radi- ology, Vol. 42, No. 2, 2007, pp. 815-822.
[83] H. Dorge, R. Schulz, S. Belosjorow, H. Post, A. van de Sand, I. Konietzka, S. Frede, T. Hartung, J. Vinten-Johansen, et al., “Coronary Microembolization: the Role of TNF-Alpha in Contractile Dysfunction,” Journal of Molecular and Cellular Cardiology, Vol. 34, No. 1, 2002, pp. 51-62.
[84] M. Canton, A. Skyschally, R. Menabo, K. Boengler, P. Gres, R. Schulz, M. Haude, R. Erbel, F. Di Lisa and G. Heusch, “Oxidative Modification of Tropomyosin and Myocardial Dysfunction Following Coronary Microem- bolization,” European Heart Journal, Vol. 27, 2006, pp. 875-881. doi:10.1093/eurheartj/ehi751
[85] A. Skyschally, P. Gres, S. Hoffmann, M. Haude, R. Erbel, R. Schulz and G. Heusch, “Bidirectional Role of Tumor Necrosis Factor-Alpha in Coronary Microembolization: Progressive Contractile Dysfunction versus Delayed Protection against Infarction,” Circulation Research, Vol. 100, No. 1, 2007, pp. 140-146.
[86] S. J. Brener and E. J. Topol, “Troponin, Embolization and Restoration of Microvascular Integrity,” European heart journal, Vol. 21, No. 14, 2000, pp. 1117-1119.
[87] J. B. Selvangyagam, K. Rahimi, A. Banning, A. Cheng, T. Pegg, T. Karamitsos, D. Taggart and S. Neubauer, “Prognostic Significance of Post-Procedural Irreversible Myocardial Injury Detected by Cardiovascular Magnetic Resonance Imaging,” Journal of Cardiovascular Magnetic Resonance, Vol.10 (Suppl 1), 2008, pp. A1 (abstract). doi:10.1186/1532-429X-10-S1-A1
[88] J. Bogaert, M. Kalantzi, F. E. Rademakers, S. Dymarkowski and S. Janssens, “Determinants and impact of Microvascular Obstruction in Successfully Reperfused ST-Segment Elevation Myocardial Infarction. Assess- ment by Magnetic Resonance Imaging,” European Radiology, Vol. 17, No. 10, 2007, pp. 2572-2580. doi:10.1007/s00330-007-0627-9
[89] J. Kotani, S. Nanto, G. S. Mintz, M. Kitakaze, T. Ohara, T. Morozumi, S. Nagata and M. Hori, “Plaque Gruel of Atheromatous Coronary Lesion May Contribute to the No-Reflow Phenomenon in Patients with Acute Coronary Syndrome,” Circulation, Vol. 106, No. 13, 2002, pp. 1672-1677. doi:10.1161/01.CIR.0000030189.27175.4E
[90] F. Prati, T. Pawlowski, R. Gil, A. Labellarte, A. Gziut, E. Caradonna, A. Manzoli, A. Pappalardo, F. Burzotta and A. Boccanelli, “Stenting of Culprit Lesions in Unstable Angina Leads to a Marked Reduction in Plaque Burden: A Major Role of Plaque Embolization? A Serial Intravascular Ultrasound Study,” Circulation, Vol. 107, No. 18, 2003, pp. 2320-2325.
[91] R. J. Frink, P. A. Rooney, Jr., J. O. Trowbridge and J. P. Rose, “Coronary Thrombosis and Platelet/Fibrin Microemboli in Death Associated with Acute Myocardial Infarction,” British Heart Journal, Vol. 59, No. 2, 1988, pp. 196-200. doi:10.1136/hrt.59.2.196
[92] P. Bahrmann, G. S. Werner, G. Heusch, M. Ferrari, T. C. Poerner, A. Voss and H. R. Figulla, “Detection of Coronary Microembolization by Doppler Ultrasound in Patients with Stable Angina Pectoris Undergoing Elective Percutaneous Coronary Interventions,” Circulation, Vol. 115, No. 5, 2007, pp. 600-608. doi:10.1161/CIRCULATIONAHA.106.660779
[93] D. Baumgart, F. Liu, M. Haude, G. Gorge, J. Ge and R. Erbel, “Acute Plaque Rupture and Myocardial Stunning in Patient with Normal Coronary Arteriography,” Lancet, Vol. 346, No. 8968, 1995, pp. 193-194. doi:10.1016/S0140-6736(95)91257-6
[94] M. Carlino, J. De Gregorio, C. Di Mario, A. Anzuini, F. Airoldi, R. Albiero, C. Briguori, A. Dharmadhikari, I. Sheiban and A. Colombo, “Prevention of Distal Embolization during Saphenous Vein Graft Lesion Angioplasty. Experience with a New Temporary occlusion and Aspiration System,” Circulation, Vol. 99, No. 25, 1999, pp. 3221-3223.
[95] E. Grube, U. Gerckens, A. C. Yeung, S. Rowold, N. Kirchhof, J. Sedgewick, J. S. Yadav and S. Stertzer, “Prevention of Distal Embolization during Coronary Angioplasty in Saphenous Vein Grafts and Native Vessels Using Porous Filter Protection,” Circulation, Vol. 104, No. 20, 2001, pp. 2436-2441. doi:10.1161/hc4501.099317
[96] U. Limbruno, A. Micheli, M. De Carlo, G. Amoroso, R. Rossini, C. Palagi, V. Di Bello, A. S. Petronio, G. Fontanini and M. Mariani, “Mechanical Prevention of Distal Embolization during Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion,” Circulation, Vol. 108, No. 2, 2003, pp. 171-176. doi:10.1161/01.CIR.0000079223.47421.78
[97] M. Murakami, K. Iwasaki, S. Kusachi, K. Hina, M. Hirota, S. Hirohata, S. Kamikawa, M. Sangawa, K. Yamamoto and Y. Shiratori, “Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting,” International Journal of Cardiology, Vol. 107, No. 1, 2006, pp. 48-53.
[98] “A Clinical Trial Comparing Primary Coronary Angioplasty with Tissue Plasminogen Activator for Acute Myocardial Infarction. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators,” New England Journal of Medicine, Vol. 336, No. 23, 1997, pp. 1621-1628. doi:10.1056/NEJM199706053362301
[99] M. Hori, M. Inoue, M. Kitakaze, Y. Koretsune, K. Iwai, J. Tamai, H. Ito, A. Kitabatake, T. Sato and T. Kamada, “Role of Adenosine in Hyperemic Response of Coronary Blood Flow in Microembolization,” American Journal of Physiology, Vol. 250, 1986, pp. H509-518.
[100] M. L. Fokkema, P. J. Vlaar, M. Vogelzang, Y. L. Gu, M. A. Kampinga, B. J. de Smet, G. A. Jessurun, R. L. Anthonio, A. F. van den Heuvel, et al., “Effect of High-Dose Intracoronary Adenosine Administration during Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: A Randomized Controlled Trial,” Circulation Cardiovascular Interventions, Vol. 2, No. 4, 2009, pp. 323-329. doi:10.1161/CIRCINTERVENTIONS.109.858977
[101] A. J. Taylor, N. Al-Saadi, H. Abdel-Aty, J. Schulz-Menger, D. R. Messroghli, M. Gross, R. Dietz and M. G. Friedrich, “Elective Percutaneous Coronary Intervention Immediately Impairs Resting Microvascular Perfusion Assessed by Cardiac Magnetic Resonance Imaging,” American Heart Journal, Vol. 151, No. 4, 2006, pp. 891.e1-7.
[102] E. Appelbaum and W. J. Manning, “Science to Practice: Can the Combination of Resting First-Pass Myocardial Perfusion and Late Gadolinium-Enhanced Cardiovascular MR Imaging Help Identify Myocardial Infarction Resulting from Coronary Microembolization?” Radiology, Vol. 250, No. 3, 2009, pp. 609-611. doi:10.1148/radiol.2503082001
[103] A. T. Yan, A. J. Shayne, K. A. Brown, S. N. Gupta, C. W. Chan, T. M. Luu, M. F. Di Carli, H. G. Reynolds, W. G. Stevenson and R. Y. Kwong, “Characterization of the Peri-Infarct Zone by Contrast-Enhanced Cardiac Magnetic Resonance Imaging is a Powerful Predictor of Post-Myocardial Infarction Mortality,” Circulation, Vol. 114, No. 1, 2006, pp. 32-39. doi:10.1161/CIRCULATIONAHA.106.613414
[104] A. Schmidt, C. F. Azevedo, A. Cheng, S. N. Gupta, D. A. Bluemke, T. K. Foo, G. Gerstenblith, R. G. Weiss, E. Marban, et al., “Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients with Left Ventricular Dys-Function,” Circulation, Vol. 115, No. 15, 2007, pp. 2006-2014. doi:10.1161/CIRCULATIONAHA.106.653568
[105] K. H. Schuleri, M. Centola, R. T. George, L. C. Amado, K. S. Evers, K. Kitagawa, A. L. Vavere, R. Evers, J. M. Hare, et al., “Characterization of Peri-Infarct Zone Heterogeneity by Contrast-enhanced Multidetector Computed Tomography: A Comparison with Magnetic Resonance Imaging,” Journal of the American College of Cardiology, Vol. 53, No. 18, 2009, pp. 1699-1707. doi:10.1016/j.jacc.2009.01.056
[106] J. M. de Bakker, F. J. van Capelle, M. J. Janse, A. A. Wilde, R. Coronel, A. E. Becker, K. P. Dingemans, N. M. van Hemel and R. N. Hauer, “Reentry as a Cause of Ventricular Tachycardia in Patients with Chronic Ischemic Heart Disease: Electrophysiologic and Anatomic Correlation,” Circulation, Vol. 77, No. 3, 1988, pp. 589-606.
[107] G. W. Stone, J. Webb, D. A. Cox, B. R. Brodie, M. Qureshi, A. Kalynych, M. Turco, H. P. Schultheiss, D. Dulas, et al., “Distal Microcirculatory Protection during Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial,” Journal of the Aemrican Medical Association, Vol. 293, No. 9, 2005, pp. 1063-1072. doi:10.1001/jama.293.9.1063
[108] J. N. Hamburger and P. W. Serruys, “Treatment of Thrombus Containing Lesions in Diseased Native Coronary Arteries and Saphenous Vein Bypass Grafts Using the AngioJet Rapid Thrombectomy System,” Herz, Vol. 22, No. 6, 1997, pp. 318-321. doi:10.1007/BF03044282
[109] T. Ischinger, “Thrombectomy with the X-SIZER Catheter System in the Coronary Circulation: Initial Results from a Multi-Center Study,” Journal of Invasive Cardiology, Vol. 13, No. 2, 2001, pp. 81-88.
[110] S. Patel and J. Hermiller, “Embolic Protection: the FilterWire EZ Embolic Protection System,” Expert Review of Medical Devices, Vol. 5, No. 1, 2008, pp. 19-24. doi:10.1586/17434440.5.1.19
[111] T. Svilaas, P. J. Vlaar, I. C. van der Horst, G. F. Diercks, B. J. de Smet, A. F. van den Heuvel, R. L. Anthonio, G. A. Jessurun, E. S. Tan, et al., “Thrombus Aspiration during Primary Percutaneous Coronary Intervention,” New England Journal of Medicine, Vol. 358, No. 6, 2008, pp. 557-567. doi:10.1056/NEJMoa0706416
[112] M. Gick, N. Jander, H. P. Bestehorn, R. P. Kienzle, M. Ferenc, K. Werner, T. Comberg, K. Peitz, D. Zohlnhofer, et al., “Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size after Primary Percutaneous Catheter Intervention in Myocardial Infarction with and without ST-Segment Elevation,” Circulation, Vol. 112, No. 10, 2005, pp. 1462-1469. doi:10.1161/CIRCULATIONAHA.105.545178
[113] M. Srinivasan, C. Rihal, D. R. Holmes and A. Prasad, “Adjunctive Thrombectomy and Distal Protection in Primary Percutaneous Coronary Intervention: Impact on Microvascular Perfusion and Outcomes,” Circulation, Vol. 119, No. 9, 2009, pp. 1311-1319. doi:10.1161/CIRCULATIONAHA.108.831453
[114] J. D. Haeck, K. T. Koch, L. Bilodeau, R. J. Van der Schaaf, J. P. Henriques, M. M. Vis, J. Baan, Jr., A. C. Van der Wal, J. J. Piek, et al., “Randomized Comparison of Primary Percutaneous Coronary Intervention with Combined Proximal Embolic Protection and Thrombus Aspiration versus Primary Percutaneous Coronary Intervention Alone in ST-Segment Elevation Myocardial Infarction: the PREPARE (Proximal Embolic Protection in Acute myocardial infarction and Resolution of ST-Elevation) Study,” JACC Cardiovascular
[115] C. M. Gibson, D. J. Cohen, E. A. Cohen, H. K. Lui, S. A. Murphy, S. J. Marble, M. Kitt, T. Lorenz and J. E. Tcheng, “Effect of Eptifibatide on Coronary Flow Reserve Following Coronary Stent Implantation (an ESPRIT Substudy). Enhanced Suppression of the Platelet IIb/IIIa Receptor with Integrilin Therapy,” Am J Cardiol, Vol. 87, No. 11, 2001, pp. 1293-1295. doi:10.1016/S0002-9149(01)01524-7
[116] H. Kunichika, O. Ben-Yehuda, S. Lafitte, N. Kunichika, B. Peters and A. N. DeMaria, “Effects of Glycoprotein IIb/IIIa Inhibition on Microvascular Flow after Coronary Reperfusion. A Quantitative Myocardial Contrast Echo- Cardiography Study,” Journal of the Americqan College of Cardiology, Vol. 43, No. 2, 2004, pp. 276-283. doi:10.1016/j.jacc.2003.08.040
[117] J. A. de Lemos, C. M. Gibson, E. M. Antman, S. A. Murphy, D. A. Morrow, K. C. Schuhwerk, M. Schweiger, P. Coussement, F. Van de Werf and E. Braunwald, “Abciximab and Early Adjunctive Percutaneous Coronary Intervention are Associated with Improved ST-Segment Resolution after Thrombolysis: Observations from the TIMI 14 Trial,” American Heart Journal, Vol. 141, No. 4, 2001, pp. 592-598. doi:10.1067/mhj.2001.113574
[118] Y. J. Yang, J. L. Zhao, S. J. You, Y. J. Wu, Z. C. Jing, W. X. Yang, L. Meng, Y. W. Wang and R. L. Gao, “Different Effects of Tirofiban and Aspirin Plus Clopidogrel on Myocardial No-Reflow in a Mini-Swine Model of Acute Myocardial Infarction and Reperfusion,” Heart, Vol. 92, No. 8, 2006, pp. 1131-1137. doi:10.1136/hrt.2005.077164

Copyright © 2023 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.